| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $200.9M | +20.2% |
| Cost of Revenue | $41.0M | +17.1% |
| Gross Profit | $159.9M | +21.0% |
| R&D Expense | $17.4M | +5.4% |
| SG&A Expense | $40.5M | +20.1% |
| Operating Income | -$22.3M | +36.6% |
| Income Tax | $0 | — |
| Net Income | -$18.9M | +38.8% |
| EPS (Basic) | -$0.44 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $42.2M | +20.9% |
| Accounts Receivable | $29.9M | +8.9% |
| Inventory | $33.9M | +25.2% |
| Current Assets | $216.1M | +4.0% |
| Total Assets | $238.6M | +3.5% |
| Current Liabilities | $25.3M | -6.8% |
| Long-term Debt | $35.6M | +0.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$675K | +94.6% |
| Capital Expenditures | $8.4M | -19.8% |
| Investing Cash Flow | $4.2M | -67.0% |
| Financing Cash Flow | $3.4M | +72.4% |
| Free Cash Flow | -$9.1M | +60.3% |
| +41.3% |
| EPS (Diluted) | -$0.44 | +41.3% |
| Total Liabilities |
| $61.0M |
| -3.9% |
| Stockholders' Equity | $177.5M | +6.3% |